Clare E. Bryant is at the Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge, CB3 OES, UK.
Nat Rev Microbiol. 2010 Jan;8(1):8-14. doi: 10.1038/nrmicro2266.
Lipopolysaccharide (LPS), which is produced by Gram-negative bacteria, is a powerful activator of innate immune responses. LPS binds to the proteins Toll-like receptor 4 (TLR4) and MD2 to activate pro-inflammatory signalling pathways. The TLR4-MD2 receptor complex is crucial for the host recognition of Gram-negative bacterial infection, and pathogens have devised many strategies to evade or manipulate TLR4-MD2 activity. The TLR4-MD2 signalling pathway is therefore potentially an important therapeutic target. This Progress article focuses on recent exciting data that have revealed the structural basis of TLR4-MD2 recognition of LPS.
脂多糖(LPS)是革兰氏阴性菌产生的一种强有力的天然免疫反应激活物。LPS 与 Toll 样受体 4(TLR4)和 MD2 蛋白结合,激活促炎信号通路。TLR4-MD2 受体复合物是宿主识别革兰氏阴性菌感染的关键,病原体已经设计了许多策略来逃避或操纵 TLR4-MD2 的活性。因此,TLR4-MD2 信号通路是一个有潜在治疗价值的靶点。这篇综述文章重点介绍了最近令人兴奋的揭示 TLR4-MD2 识别 LPS 的结构基础的数据。